Niuruite Medical
Latest round
- Series E
Last raised
- Apr 2026
Total raised
- $332M
Investors
- 32
About Niuruite Medical
, trading as Niuruite Medical, was founded by a team of nuclear industry scientists including former senior members of the China National Nuclear Corporation. Niuruite Medical develops and produces a range of radiopharmaceuticals and isotopes used in the diagnosis and treatment of malignant tumors. Its portfolio includes radioactive glass microspheres, radioactive embolization microspheres, and various nuclides such as Ge-68 and Ac-225. The company operates China’s first commercial 30MeV IKON proton accelerator and is advancing multiple clinical-stage nuclear drug candidates, including NRT6003 (for liver cancer) and NRT6008 (for pancreatic cancer). The company generates revenue from sales of medical isotopes, radiopharmaceutical products, and related technical consulting services to hospitals, research institutes, and pharmaceutical companies., in order to consolidate the company's leading position in the field of domestic medical isotopes and radiopharmaceuticals.
Who invested in Niuruite Medical
32 investors across 5 rounds
See all investors in Niuruite Medical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Niuruite Medical
Who invested in Niuruite Medical?
Niuruite Medical has 32 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Niuruite Medical raised?
Niuruite Medical has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Niuruite Medical last raise money?
Niuruite Medical's most recent round on record is a Series E, in Apr 2026.
What does Niuruite Medical do?
, trading as Niuruite Medical, was founded by a team of nuclear industry scientists including former senior members of the China National Nuclear Corporation.
Where is Niuruite Medical headquartered?
Niuruite Medical is headquartered in Chengdu, China.
Which VCs invest in companies like Niuruite Medical?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Niuruite Medical's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series E
Raising like Niuruite Medical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.